ConductScience.org, home

Paper39124690

Turning the Tide against Herpes Zoster in Rheumatoid Arthritis Patients Treated with JAK Inhibitors.

Cito A and 6 others. J Clin Med, 2024. Cited by 7 papers, by iCite.

Cite this record

ConductScience Library. Turning the Tide against Herpes Zoster in Rheumatoid Arthritis Patients Treated with JAK Inhibitors. Papers, record 39124690. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39124690

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Turning the Tide against Herpes Zoster in Rheumatoid Arthritis Patients Treated with JAK Inhibitors.
PubMed
Journal
J Clin Med
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
1.33, provisional
iCite
Revised in PubMed
2024-08-12
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cito AAndrea
2Fornaro MMarco
3Carenza AAngela
4Anelli MGMaria Grazia
5Scioscia CCrescenziohttps://orcid.org/0000-0003-0941-8182
6Iannone FFlorenzohttps://orcid.org/0000-0003-0474-5344
7Lopalco GGiuseppehttps://orcid.org/0000-0003-4524-9566

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References55

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
122873531Tofacitinib or adalimumab versus placebo in rheumatoid arthritis.N Engl J Med2012https://conductscience.org/library/papers/22873531PubMed
212209125Stats: transcriptional control and biological impact.Nat Rev Mol Cell Biol2002https://conductscience.org/library/papers/12209125PubMed
326990731Risk of Herpes Zoster in Autoimmune and Inflammatory Diseases: Implications for Vaccination.Arthritis Rheumatol2016https://conductscience.org/library/papers/26990731PubMed
423740236Evaluation of the RABBIT Risk Score for serious infections.Ann Rheum Dis2014https://conductscience.org/library/papers/23740236PubMed
531287230Upadacitinib Versus Placebo or Adalimumab in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate: Results of a Phase III, Double-Blind, Randomized Controlled Trial.Arthritis Rheumatol2019https://conductscience.org/library/papers/31287230PubMed
629081988Infection rates in patients from five rheumatoid arthritis (RA) registries: contextualising an RA clinical trial programme.RMD Open2017https://conductscience.org/library/papers/29081988PubMed
733763912Cigarette smoking and risk of herpes zoster: a population-based cohort study in Taiwan.Clin Exp Dermatol2021https://conductscience.org/library/papers/33763912PubMed
834706874Safety of baricitinib for the treatment of rheumatoid arthritis over a median of 4.6 and up to 9.3 years of treatment: final results from long-term extension study and integrated database.Ann Rheum Dis2022https://conductscience.org/library/papers/34706874PubMed
928130918Anifrolumab, an Anti-Interferon-α Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus Erythematosus.Arthritis Rheumatol2017https://conductscience.org/library/papers/28130918PubMed
1018505138Herpes zoster in eastern Saudi Arabia: clinical presentation and management.J Drugs Dermatol2008https://conductscience.org/library/papers/18505138PubMed
1134671868Adverse Effects of Immunosuppression: Infections.Handb Exp Pharmacol2022https://conductscience.org/library/papers/34671868PubMed
1217676033Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome.Nature2007https://conductscience.org/library/papers/17676033PubMed
1329568506Recent advances in antiviral interferon-stimulated gene biology.F1000Res2018https://conductscience.org/library/papers/29568506PubMed
1429079160Herpes Zoster in the Older Adult.Infect Dis Clin North Am2017https://conductscience.org/library/papers/29079160PubMed
1526478818Herpes zoster epidemiology, management, and disease and economic burden in Europe: a multidisciplinary perspective.Ther Adv Vaccines2015https://conductscience.org/library/papers/26478818PubMed
1615471658Treatment of postherpetic neuralgia: a review of therapeutic options.J Pain Symptom Manage2004https://conductscience.org/library/papers/15471658PubMed
176195526Varicella and herpes zoster. Changing concepts of the natural history, control, and importance of a not-so-benign virus.N Engl J Med1983https://conductscience.org/library/papers/6195526PubMed
1835215786Herpes zoster: A Review of Clinical Manifestations and Management.Viruses2022https://conductscience.org/library/papers/35215786PubMed
1937108130Immunogenicity and Safety of Adjuvanted Recombinant Zoster Vaccine in Rheumatoid Arthritis Patients on Anti-Cellular Biologic Agents or JAK Inhibitors: A Prospective Observational Study.Int J Mol Sci2023https://conductscience.org/library/papers/37108130PubMed
2026611557Infection Risk and Safety of Corticosteroid Use.Rheum Dis Clin North Am2016https://conductscience.org/library/papers/26611557PubMed

See all 55 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
42194695Herpes Zoster in Patients Treated with JAK Inhibitors for Immune-Mediated Inflammatory Diseases: Incidence, Associated Factors and Vaccination Uptake in a Real-World Cohort.J Clin Med2026https://conductscience.org/library/papers/42194695PubMed
42183272Prevalence and risk factors of herpes zoster in patients with rheumatoid arthritis: a systematic review and meta-analysis.Front Immunol2026https://conductscience.org/library/papers/42183272PubMed
41710062Herpes Zoster Risk in Rheumatoid Arthritis Patients on Janus Kinase Inhibitors: A 17-Year Experience from Rheumatoid Arthritis Saudi Database (RASD).Open Access Rheumatol2026https://conductscience.org/library/papers/41710062PubMed
41441693Effectiveness and Safety of Recombinant Zoster Vaccine in Rheumatic Diseases: Real-World Evidence from a Single-Centre Italian Cohort.Vaccines (Basel)2025https://conductscience.org/library/papers/41441693PubMed
41371648Preventive Effectiveness of Recombinant Zoster Vaccine in Rheumatoid Arthritis Patients Treated with Janus Kinase Inhibitors.Intern Med2026https://conductscience.org/library/papers/41371648PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39124690

GET https://conductscience.org/api/papers/v1/39124690/references?page=2